Display options
Cite
Yasmin-Karim S, Moreau M, Mueller R, et al. Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids. Front Oncol. 2018;8:114doi: 10.3389/fonc.2018.00114.
Yasmin-Karim, S., Moreau, M., Mueller, R., Sinha, N., Dabney, R., Herman, A., & Ngwa, W. (2018). Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids. Frontiers in oncology, 8114. https://doi.org/10.3389/fonc.2018.00114
Yasmin-Karim, Sayeda, et al. "Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids." Frontiers in oncology vol. 8 (2018): 114. doi: https://doi.org/10.3389/fonc.2018.00114
Yasmin-Karim S, Moreau M, Mueller R, Sinha N, Dabney R, Herman A, Ngwa W. Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids. Front Oncol. 2018 Apr 24;8:114. doi: 10.3389/fonc.2018.00114. eCollection 2018. PMID: 29740535; PMCID: PMC5928848.
Copy Download .nbib Format: NLM
Share it on

Front Oncol. 2018 Apr 24;8:114. doi: 10.3389/fonc.2018.00114. eCollection 2018.

Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids.

Frontiers in oncology

Sayeda Yasmin-Karim, Michele Moreau, Romy Mueller, Neeharika Sinha, Raymond Dabney, Allen Herman, Wilfred Ngwa

Affiliations

  1. Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States.
  2. Dana-Farber Cancer Institute, Boston, MA, United States.
  3. Harvard Medical School, Boston, MA, United States.
  4. University of Massachusetts Lowell, Lowell, MA, United States.
  5. University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
  6. Cannabis Science, Inc., Irvine, CA, United States.

PMID: 29740535 PMCID: PMC5928848 DOI: 10.3389/fonc.2018.00114

Abstract

Over the years, many

Keywords: biomaterials; cancer; cannabinoids or endocannabinoids; radiotherapy; survival

References

  1. Sci Rep. 2017 Jun 9;7(1):3165 - PubMed
  2. Clin Cancer Res. 2007 Jun 15;13(12):3637-41 - PubMed
  3. Cancer Res. 2008 Mar 15;68(6):1945-52 - PubMed
  4. Nat Commun. 2014 Dec 18;5:5870 - PubMed
  5. Cancer Res. 2014 Jun 1;74(11):2913-21 - PubMed
  6. Nat Rev Clin Oncol. 2014 Feb;11(2):66 - PubMed
  7. BMC Biol. 2010 May 19;8:59 - PubMed
  8. Nat Rev Cancer. 2018 May;18(5):313-322 - PubMed
  9. Nat Neurosci. 2007 Jul;10(7):870-9 - PubMed
  10. Nat Rev Cancer. 2003 Oct;3(10):745-55 - PubMed
  11. Br J Cancer. 2006 Jul 17;95(2):197-203 - PubMed
  12. Oncogene. 2008 Jan 10;27(3):339-46 - PubMed
  13. Mol Cancer Ther. 2011 Jul;10(7):1161-72 - PubMed
  14. Nanomedicine. 2013 Jan;9(1):25-7 - PubMed
  15. N Engl J Med. 2014 Nov 27;371(22):2140-1 - PubMed
  16. Cancer Manag Res. 2013 Aug 30;5:301-13 - PubMed
  17. Nano Lett. 2016 Apr 13;16(4):2334-40 - PubMed
  18. Nat Rev Cancer. 2012 May 04;12 (6):436-44 - PubMed
  19. Acta Pharm Sin B. 2014 Apr;4(2):120-7 - PubMed
  20. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):615-23 - PubMed
  21. Radiat Oncol J. 2017 Mar;35(1):55-64 - PubMed
  22. Biochem Pharmacol. 2014 Nov 15;92(2):312-25 - PubMed
  23. Front Oncol. 2017 Sep 19;7:208 - PubMed
  24. Clin Pharmacokinet. 2003;42(4):327-60 - PubMed
  25. Radiat Res. 2011 Dec;176(6):816-20 - PubMed
  26. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):624-637 - PubMed
  27. Clin Pharmacol Ther. 2015 Jun;97(6):575-86 - PubMed
  28. Methods Mol Med. 2005;110:21-8 - PubMed
  29. Mol Cancer Ther. 2014 Dec;13(12):2955-67 - PubMed

Publication Types